skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

Bacterial Respiratory

(Last updated: September 1, 2014; last reviewed: September 1, 2014)

Bacterial Respiratory Disease

Member Financial Disclosure
Company Relationship
Crothers, Kristina*
University of Washington None N/A
Miller, Robert
University College London, England
Gilead Honoraria, Speaker’s Bureau
Mark Allen Healthcare 
Honoraria
Merck Honoraria, Speaker’s Bureau
Moore, Matthew
Centers for Disease Control and Prevention
None N/A
Morris, Alison
University of Pittsburgh Medical School
Cape Cod Association
Research Support
Gilead Research Support
NIH Research Support
Roche Research Support
Niederman, Michael
Winthrop University Hospital
Bayer Advisory Board, Honoraria, Research Support
Cubist Research Support
Merck Advisory Board
Pfizer Advisory Board, Honoraria
Thermo-Fisher
Honoraria

* Group lead

Note: Members were asked to disclose all relationships from 24 months prior to the updated date. The period of reporting was from September 1, 2012 through September 1, 2014.

Back to Top